| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.92B | 68.87B | 64.55B | 67.38B | 61.48B | 60.73B |
| Gross Profit | 11.98B | 12.47B | 11.66B | 12.62B | 10.83B | 10.39B |
| EBITDA | 6.99B | 7.34B | 6.94B | 8.17B | 6.84B | 6.99B |
| Net Income | 3.73B | 3.38B | 3.71B | 4.63B | 3.92B | 3.78B |
Balance Sheet | ||||||
| Total Assets | 76.37B | 82.77B | 77.57B | 72.92B | 66.79B | 60.95B |
| Cash, Cash Equivalents and Short-Term Investments | 17.40B | 15.60B | 20.21B | 20.23B | 14.59B | 14.00B |
| Total Debt | 3.20B | 5.08B | 3.52B | 3.52B | 4.11B | 5.06B |
| Total Liabilities | 25.22B | 29.58B | 26.30B | 22.96B | 25.17B | 21.96B |
| Stockholders Equity | 51.11B | 53.13B | 51.27B | 49.96B | 41.62B | 38.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.05B | 5.42B | 3.74B | 3.17B | 7.55B |
| Operating Cash Flow | 0.00 | -132.00M | 7.80B | 5.27B | 4.08B | 8.69B |
| Investing Cash Flow | 0.00 | -2.86B | -5.21B | -996.00M | -1.23B | -1.94B |
| Financing Cash Flow | 0.00 | -1.48B | -2.90B | 2.00B | -2.26B | -2.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥52.90B | 11.77 | ― | 4.90% | -4.13% | 19.71% | |
70 Outperform | ¥49.04B | 12.38 | ― | 3.78% | 24.67% | 72.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥44.12B | 14.25 | ― | 3.53% | 6.68% | -6.70% | |
63 Neutral | ¥43.94B | 10.01 | ― | 2.26% | 17.46% | 102.48% | |
63 Neutral | ¥42.56B | 14.02 | ― | 5.38% | -24.18% | -32.34% | |
60 Neutral | ¥60.23B | 13.89 | ― | 1.57% | 4.01% | 21.41% |